Navigation Links
Scaffolding protein promotes growth and metastases of epithelial ovarian cancer
Date:4/6/2014

omen every year. The disease kills about 14,000, according to the American Cancer Society. It is the fifth leading cause of cancer death in women and one of the most common gynecologic cancers. In most patients, the disease has already metastasized at the time of diagnosis.

Connolly, whose research focuses on understanding the molecular underpinnings of epithelial ovarian cancer, says she and her colleagues became interested in NEDD9 after learning about its role in other cancers. The protein was discovered in 1996 by Fox Chase Professor Erica A. Golemis, PhD, Co-Leader of the Center's Developmental Therapeutics Research Program and a co-author on the ovarian cancer study.

Proteins like NEDD9 control and regulate the signaling mechanisms between the surface and interior of a cell.

"At the time our research started, we saw an early report suggesting that high-level NEDD9 expression was part of a gene signature related to advanced stage ovarian cancer," says Connolly, senior author on the study.

To study the protein's role in epithelial ovarian cancer, Gabbasov and his colleagues compared tumor growth in two groups of mice bred to spontaneously develop ovarian tumors. Mice in one group lacked NEDD9, and mice in the other group expressed the protein. Using MRI scans, the researchers observed delayed tumor development in the NEDD9-null mice, compared to mice that expressed NEDD9. Analysis of tumor tissue showed more activity in several well-known oncogenic signaling pathways in the mice expressing the protein.

"When we compared the gene expression in these tumors, we were able to see how NEDD9 depletion really affects overall gene expression," says Gabbasov. "It really does affect numerous genes, and we will try to pursue these gene products to better understand the role of NEDD9."

Connolly says that even though this study looked at the ovarian cancer in mice, some of the genes that turned up in the gene express
'/>"/>

Contact: Diana Quattrone
Diana.Quattrone@fccc.edu
215-815-7828
Fox Chase Cancer Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Cell scaffolding protein fascin-1 is hijacked by cancer
2. Smart scaffolding aims to rebuild tissue from the inside
3. Cancer researchers find key protein link
4. Velcro protein found to play surprising role in cell migration
5. Scientists discover new protein involved in lung cancer
6. Brain cell activity regulates Alzheimer’s protein
7. Tumors light up with new, unique imaging system using scorpion venom protein and a laser
8. Study in fruitflies strengthens connection among protein misfolding, sleep loss, and age
9. NUS researchers make new discovery of protein as a promising target for treatment of ATC
10. A new target for cancer and diabetes: A novel role for the adaptor protein p66shc in regulating glucose metabolism
11. Exon skipping prevents formation of toxic protein fragments in Huntingtons disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 2014 issue of The FASEB Journal ... a simple blood test. This test, called the "lymphocyte genome ... than ever before, but it may eliminate the need for ... likely to develop cancer in the future. , "The ... peoples, lives," said Diana Anderson, a researcher involved in the ...
(Date:9/30/2014)... HealthDay Reporter MONDAY, Sept. 29, 2014 ... -- artificial valves, hip replacements, surgical mesh and the like ... after their approval by the U.S. Food and Drug Administration, ... prominent nonprofit groups and published online Sept. 29 in ... medical device testing on lax oversight by the FDA. ...
(Date:9/30/2014)... 30, 2014 Edward D. Buckingham, M.D., ... has been approved to be a director of a ... Reconstructive Surgery (AAFPRS) fellowship program. The announcement came last ... Florida. , The Educational and Research Foundation for the ... It represents the finest postgraduate program in the world ...
(Date:9/30/2014)... NC (PRWEB) September 30, 2014 ... and caring individuals, National Children’s Oral Health ... $150,000 in grants to non-profit clinical partners. ... Affiliate Network and deliver comprehensive educational, preventive ... , Recipients include:,     Just ...
(Date:9/30/2014)... TUESDAY, Sept. 30, 2014 (HealthDay News) -- Herceptin is ... cancer called HER2-positive and should remain the standard of ... findings from a long-term clinical trial. HER2-positive breast ... of breast cancer, according to the Mayo Clinic. ... countries received either Herceptin (trastuzumab) or Tykerb (lapatinib) in ...
Breaking Medicine News(10 mins):Health News:New blood test determines whether you have or are likely to get cancer 2Health News:Medical Implant Devices Skate Through Review Process, Studies Claim 2Health News:Medical Implant Devices Skate Through Review Process, Studies Claim 3Health News:Medical Implant Devices Skate Through Review Process, Studies Claim 4Health News:Dr. Edward Buckingham Approved to be Fellowship Director for Facial Plastic Surgery 2Health News:Dr. Edward Buckingham Approved to be Fellowship Director for Facial Plastic Surgery 3Health News:America's ToothFairy Awards More Than $150,000 in Grants to Save Young Smiles 2Health News:America's ToothFairy Awards More Than $150,000 in Grants to Save Young Smiles 3
... Dr. Jacob Bolotin Awards Presented at 2008 Convention, ... of,the Blind presented $100,000 in cash awards to ... achieving the,full integration of the blind into society ... Bolotin Awards honored ten innovators in the blindness,field ...
... 7 The Peer Group, a leading provider,of ... an,Informed Medical Communications (IMC) company, today announced the ... innovation in moderated,peer influence events whereby two Key ... data, product attributes, and prescribing,experience in a debate-style ...
... of potent, or ,high affinity, antibodies to fight infection. The ... it hinges on a single molecule, a growth factor, without ... do not yet understand about our immune system. In simple ... T cells, which help them. Ways in which these cells ...
... BETHLEHEM, Pa., July 7 MIKE AND IKE(R) Lemonade,Blends(TM) ... candy fans who are members of the facebook(R) community ... To view the Multimedia News Release, go to:, http://www.prnewswire.com/mnr/justborn/33812/ ... Foundation will encourage,their fans who are active on facebook(R) ...
... Corporation (Pink,Sheets: BDRR), a medical imaging and diagnostic ... Network (OTCFN), a division of National,Financial Communications Corp., ... president of OTCFN, said, "In 2007, Bederra generated,revenues ... $471,182, or,approximately $0.01 per share, and has some ...
... Engage Contract Sales Organization And Seek New Marketing ... Partner to Promote Product in UK -, ... DDSS) today announced that it has reacquired the sales and,marketing rights ... Recordati Ireland Ltd. (Recordati). To promote its,product in the UK, the ...
Cached Medicine News:Health News:National Federation of the Blind Awards $100,000 2Health News:The Peer Group Launches Xpert Xchange(SM), an Innovation in Medical Peer Influence Programs 2Health News:Finding suggests novel ways to boost vaccination or natural defenses 2Health News:Photos: MIKE AND IKE(R) Lemonade Blends(TM) and Alex's Lemonade Stand Foundation Join facebook(R) 2Health News:Photos: MIKE AND IKE(R) Lemonade Blends(TM) and Alex's Lemonade Stand Foundation Join facebook(R) 3Health News:Bederra Corporation Retains OTC Financial Network for Investor Relations 2Health News:Bederra Corporation Retains OTC Financial Network for Investor Relations 3Health News:Labopharm Reaquires UK Sales And Marketing Rights to Its Once-Daily Tramadol Product 2
(Date:9/30/2014)... , Sept. 30, 2014 The Eastern ... Both established medical-device providers as well as new medical-device ... region, while simultaneously looking at ways to reduce the ... Using distributors is one of the effective means to ... devices distribution market in Eastern European and provides profiles ...
(Date:9/30/2014)... New York , September 30, 2014 ... - Global Industry Analysis, Market Size, Share, Growth and ... is expected to be worth USD 20.8 billion in ... billion in 2017, growing at a CAGR of 7.3% ... fundamental elements needed for various health purposes, especially to ...
(Date:9/30/2014)... 30, 2014 In a recent ... Fluid) backflow of the Eldor spinal needle 25G, 103 ... hole pencil point spinal needles of the same gauge ... Spinal anesthesia is an excellent type of regional anesthesia ... Anesthesia, etc. It is estimated that 100 ...
Breaking Medicine Technology:Medical Technologies Distributor Profiles in Eastern Europe 2Medical Technologies Distributor Profiles in Eastern Europe 3Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 2Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 3Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 4
... Mich., Nov. 9 Thomson Reuters today ... leading clinical surveillance solution that enables hospitals to identify ... clinical quality and reduce total cost of treatment. , ... no additional cost. , CareFocus 2.0 contains ...
... Shire plc (LSE: SHP, Nasdaq: ... availability of INTUNIV (TM) (guanfacine) Extended Release ... of Attention-Deficit/Hyperactivity Disorder ( ADHD ) in children ... formulation of guanfacine, is the first and only nonscheduled alpha-2A ...
Cached Medicine Technology:Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 3Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 2Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 3Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 4Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 5Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 6Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 7
Remote Controlled, Easy to Use,Vision Tester Designed for Screening Children Ages 3 and Older.,Excellent for Pediatric and School Markets....
Contrast Sensitivity is Recognized as a Valuable Tool for Measuring Functional Vision Loss Caused by Early Eye Disease. Distance Test S.W.C.T. 201: Size 27in x 37 in (68.58cm x 93.98cm),Can be Wal...
Vision Testing for Infants and Non-Verbal Patients,Using Preferential Looking....
Adult: Letter Acuity, Astigmatic Clock, Binocular Balance, Supression, Fixation Disparity, Stereopsis...
Medicine Products: